Merger control in the context of M&A deals and the health and life sciences sector

Hear from our Life Sciences and Competition teams, including partners Steven Hacking, Peter Harper, Josh Shapiro, Martin Bechtold, Jeff Bialos and Claire Morgan as they explore the issues competition regulators focus on when they assess M&A; deals in the sector and discuss topics such as the continued digitalization of healthcare and lessons learned, offering perspectives from both Europe and the US.